You Position: Home > Paper
Novel biomarkers for progression of chronic kidney disease
( views:82, downloads:0 )
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 13
- DOI:
- 10.3760/cma.j.issn.0366-6999.2010.13.032
- Key Word:
- chronic kidney disease;renal fibrosis;disease biomarker;proteomics
Abstract： @@ CHARACTERISTICS OF THE PROGRESSION OF CHRONIC KIDNEY DISEASE (CKD)Although there are different initiators of CKD, it is generally recognized that the secondary pathological pathway is quite common to all CKD. CKD may inevitably progress to end stage renal disease (ESRD) due to a vicious cycle of nephron destruction by progressive glomerulosclerosis and tubulointerstitial fibrosis.
- [1]Petra, Zürbig,Harald, Mischak.Capillary electrophoresis coupled to mass spectrometry for biomarker discovery and diagnosis of kidney diseases.[J].2008,160.
- [2]Liu BC,Lv LL.High-throughput antibody microarrays for quantitative proteomic analysis.[J].2007,4(4).
- [3]Yokota H,Suzuki H,Yuri M,etc.Absence of increased alpha1-microglobulin in IgA nephropathy proteinuria.[J].2007,6(4).
- [4]Knepper,M.A.,Ronco,P.,Langham,R.G.,etc.Towards standard protocols and guidelines for urine proteomics: A report on the Human Kidney and Urine Proteome Project (HKUPP) symposium and workshop - 6 October 2007, Seoul, Korea and 1 November 2007, San Francisco, CA, USA[J].2008,8(11).
- [5]Suthanthiran M,Gerber LM,Schwartz JE.Circulating transforming growth factor-beta1 levels and the risk for kidney disease in African Americans.[J].2009,76(1).
- [6]Nakamura T,Sugaya T,Kawagoe Y,etc.Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.[J].2005,28(11).
- [7]Ian, Wu,Chirag R, Parikh.Screening for kidney diseases: older measures versus novel biomarkers.[J].2008,3(6).
- [8]Tarnow L,Zurbig P,Rossing P,etc.Urinary proteomics in diabetes and CKD.[J].2008,19(7).
- [9]Anderson S,Halter JB,Hazzard WR,etc.Prediction, progression, and outcomes of chronic kidney disease in older adults.[J].2009,20(6).
- [10]van-Nieuwenhoven FA,Rossing P,Ito Y,etc.Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy.[J].2008,31(6).
- [11]Connolly JO,Woolfson RG.A critique of clinical guidelines for detection of individuals with chronic kidney disease.[J].2009,111(1).
- [12]Visith Thongboonkerd.Biomarker discovery in glomerular diseases using urinary proteomics[J].2008,2(10).
- [13]van-Timmeren MM,Bakker SJ,van-den-Heuvel MC,etc.Tubular kidney injury molecule-1 (KIM-1) in human renal disease.[J].2007,212(2).
- [14]El Nahas AM.Plasticity of kidney cells: Role in kidney remodeling and scarring.[J].2003,64(5).
- [15]Lee SK,Sato Y,Wiggins JE,etc.Urine podocyte mRNAs mark progression of renal disease.[J].2009,20(5).
- [16]Sugaya T,Yokoyama T,Kamijo Ikemori A,etc.Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage.[J].2009,174(6).
- [17]Smilde AK,Smit S,Hoefsloot HCJ.Statistical data processing in clinical proteomics[J].2008,866(1).
- [18]Damman K,Vaidya VS,Waanders F,etc.Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.[J].2009,53(1).
- [19]Mori K,Omata M,Satoh N,etc.Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons.[J].2009,75(3).
- [20]Devarajan P,Nickolas TL,Barasch J.Biomarkers in acute and chronic kidney disease.[J].2008,17(2).